CHEVION MORDECHAI has a total of 36 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2010. It filed its patents most often in EPO (European Patent Office), Canada and China. Its main competitors in its focus markets pharmaceuticals, environmental technology and organic fine chemistry are IRR INC, SUMMA HEALTH SYSTEM and TELORMEDIX SA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | Canada | 4 | |
#3 | China | 4 | |
#4 | Republic of Korea | 4 | |
#5 | Singapore | 4 | |
#6 | United States | 4 | |
#7 | WIPO (World Intellectual Property Organization) | 4 | |
#8 | Australia | 3 | |
#9 | Israel | 2 | |
#10 | Japan | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Environmental technology | |
#3 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Climate change adaptation technologies | |
#4 | Heterocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Chevion Mordechai | 36 |
#2 | Vinokur Vladimir | 35 |
#3 | Berenshtein Eduard | 20 |
#4 | Eliashar Ron | 13 |
#5 | Bulvik Baruch | 5 |
#6 | Ron Eliashar | 1 |
#7 | Eduard Berenshtein | 1 |
#8 | Vladimir Vinokur | 1 |
Publication | Filing date | Title |
---|---|---|
CN112153967A | Compositions and methods for treating demyelination | |
AU2019255355A1 | Compositions and methods for treatment of iron overload | |
KR20180105701A | Methods and pharmaceutical compositions for the treatment of neurodegeneration | |
KR20170096194A | Metal complexes of novel nocardamine and uses thereof in pharmaceutical compositions |